$MRNA News

Moderna (MRNA) Stock May Be Fully Priced As Melanoma Vaccine Data Leaks

Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial

Moderna, Inc. (MRNA) Discusses Phase III Data for Intismeran and Advances in Cancer Immunotherapy Transcript

Moderna’s Stock Just Stumbled. Is It a Buy on the Dip?

ESMO26: MSD and Moderna drop cancer vaccine trial data early

William Blair analyst on Moderna’s stock plunge following cancer vaccine data leaks

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Moderna Named a Top Employer by Science for Twelfth Consecutive Year

Nasdaq, Dow, S&P 500 Futures Drop Premarket: NVDA, AMD, META, CRWV, MRNA, WDC, BE In Focus

Moderna Sinks 18% on Leaked Melanoma Data: “Benefit Was Greater After Six Months”

After Moderna's 672% Climb, The Story Has Changed

Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports

Watching Moderna; Shares Plunge ~15% After Popular YouTuber TOGI Reveals Full-Portfolio Put Position Against The Stock

Moderna (MRNA) Starts Late Stage Trial For mRNA Bird Flu Vaccine

Is Moderna (MRNA) Fully Valued Following Its NASDAQ 100 Inclusion?

Moderna (MRNA) Rises Higher Than Market: Key Facts

Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance?

TD Cowen Maintains Hold on Moderna, Raises Price Target to $90

What's Going On With Moderna Stock Monday?

Phase 3 Cancer Vaccine Success Could Change The Case For Moderna Stock